Because they now have the funds to run multiple phase three trials and don't need to partner with big pharma. Big pharma now need us more than we need them.
The last time a CR was held we lost more than a QTR of the company however the SP tripled in the following months. Hang in there.
VLA Price at posting:
65.0¢ Sentiment: Buy Disclosure: Held